BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110]
URL: https://www.wjgnet.com/1948-5182/full/v8/i26/1110.htm
Number Citing Articles
1
Dana Balitzer, Sanjay Kakar. Diagnostic challenges and risk stratification of hepatocellular adenomaDiagnostic Histopathology 2022; 28(2): 89 doi: 10.1016/j.mpdhp.2021.11.003
2
Jae Young Lee, Yasunori Minami, Byung Ihn Choi, Won Jae Lee, Yi-Hong Chou, Woo Kyoung Jeong, Mi-Suk Park, Nobuki Kudo, Min Woo Lee, Ken Kamata, Hiroko Iijima, So Yeon Kim, Kazushi Numata, Katsutoshi Sugimoto, Hitoshi Maruyama, Yasukiyo Sumino, Chikara Ogawa, Masayuki Kitano, Ijin Joo, Junichi Arita, Ja-Der Liang, Hsi-Ming Lin, Christian Nolsoe, Odd Helge Gilja, Masatoshi Kudo. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using SonazoidUltrasonography 2020; 39(3): 191 doi: 10.14366/usg.20057
3
Michael Torbenson. Hepatic AdenomasSurgical Pathology Clinics 2018; 11(2): 351 doi: 10.1016/j.path.2018.02.007
4
Paulette Bioulac‐Sage, Annette S H Gouw, Charles Balabaud, Christine Sempoux. Hepatocellular adenoma: what we know, what we do not know, and why it mattersHistopathology 2022; 80(6): 878 doi: 10.1111/his.14605